Press Releases

Our latest news and press releases

All 2024 2023 2022 2021 2020 2019

11 Dec 2021
10:11 E.S.T.

Cellectis Reports Encouraging Clinical Data from BALLI-01 Study in Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, and Preclinical Data from TALGlobin01 at the 63rd American Society of Hematology Annual Meeting

18 Nov 2021
13:44 E.S.T.

Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK Partnership to Enable Broader Collaboration in China

11 Nov 2021
17:19 E.S.T.

Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Product Candidate Targeting Mesothelin to Treat Solid Tumors at the Annual Meeting of the Society for Immunotherapy of Cancer

04 Nov 2021
14:51 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021

03 Nov 2021
18:40 E.S.T.

Cellectis Announces Release of Abstracts at ASH Showcasing Updated Preliminary Clinical Data from BALLI-01 Study and First Preclinical Data from TALGlobin01

28 Oct 2021
11:08 E.S.T.

Cellectis to Hold Third Quarter Earnings Call on Friday, November 5, 2021 at 8AM EDT